 | • レポートコード：MRC2102QY16113 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のウイルスワクチン市場について種類別（弱毒化ワクチン、不活化ワクチン）、用途別（病院、製薬工場、研究所、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ウイルスワクチン市場の概要 ・世界の主要地域別ウイルスワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のウイルスワクチン市場規模2015-2026：種類別（弱毒化ワクチン、不活化ワクチン） ・世界のウイルスワクチン市場規模2015-2026：用途別（病院、製薬工場、研究所、その他） ・ウイルスワクチンの米国市場規模2015-2020 ・ウイルスワクチンのヨーロッパ市場規模2015-2020 ・ウイルスワクチンの中国市場規模2015-2020 ・ウイルスワクチンの日本市場規模2015-2020 ・ウイルスワクチンの東南アジア市場規模2015-2020 ・ウイルスワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・ウイルスワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ウイルスワクチンの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Viral Vaccines Market
The global Viral Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Viral Vaccines Scope and Market Size
The global Viral Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Viral Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Viral Vaccines market is segmented into
Attenuated Vaccine
Inactivated Vaccine
Segment by Application, the Viral Vaccines market is segmented into
Hospital
Pharmaceutical Factory
Research Institute
Others
The Viral Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the Viral Vaccines market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Viral Vaccines Market Share Analysis
Viral Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Viral Vaccines business, the date to enter into the Viral Vaccines market, Viral Vaccines product introduction, recent developments, etc.
The major vendors covered:
GSK
Merck
Novartis
Pfizer
Sanofi
Bayer
Zoetis
AstraZeneca
Johnson
CSL
1 Viral Vaccines Market Overview
1.1 Viral Vaccines Product Scope
1.2 Viral Vaccines Segment by Type
1.2.1 Global Viral Vaccines Sales by Type (2020-2026)
1.2.2 Attenuated Vaccine
1.2.3 Inactivated Vaccine
1.3 Viral Vaccines Segment by Application
1.3.1 Global Viral Vaccines Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Pharmaceutical Factory
1.3.4 Research Institute
1.3.5 Others
1.4 Viral Vaccines Market Estimates and Forecasts (2015-2026)
1.4.1 Global Viral Vaccines Sales Growth Rate (2015-2026)
1.4.2 Global Viral Vaccines Revenue and Growth Rate (2015-2026)
1.4.3 Global Viral Vaccines Price Trends (2015-2026)
2 Viral Vaccines Estimate and Forecast by Region
2.1 Global Viral Vaccines Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Viral Vaccines Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Viral Vaccines Sales Market Share by Region (2015-2020)
2.2.2 Global Viral Vaccines Revenue Market Share by Region (2015-2020)
2.3 Global Viral Vaccines Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Viral Vaccines Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Viral Vaccines Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Viral Vaccines Estimates and Projections (2015-2026)
2.4.2 Europe Viral Vaccines Estimates and Projections (2015-2026)
2.4.3 China Viral Vaccines Estimates and Projections (2015-2026)
2.4.4 Japan Viral Vaccines Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Viral Vaccines Estimates and Projections (2015-2026)
2.4.6 India Viral Vaccines Estimates and Projections (2015-2026)
3 Global Viral Vaccines Competition Landscape by Players
3.1 Global Top Viral Vaccines Players by Sales (2015-2020)
3.2 Global Top Viral Vaccines Players by Revenue (2015-2020)
3.3 Global Viral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vaccines as of 2019)
3.4 Global Viral Vaccines Average Price by Company (2015-2020)
3.5 Manufacturers Viral Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Viral Vaccines Players (Opinion Leaders)
4 Global Viral Vaccines Market Size by Type
4.1 Global Viral Vaccines Historic Market Review by Type (2015-2020)
4.1.1 Global Viral Vaccines Sales Market Share by Type (2015-2020)
4.1.2 Global Viral Vaccines Revenue Market Share by Type (2015-2020)
4.1.3 Global Viral Vaccines Price by Type (2015-2020)
4.2 Global Viral Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Viral Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Viral Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Global Viral Vaccines Price Forecast by Type (2021-2026)
5 Global Viral Vaccines Market Size by Application
5.1 Global Viral Vaccines Historic Market Review by Application (2015-2020)
5.1.1 Global Viral Vaccines Sales Market Share by Application (2015-2020)
5.1.2 Global Viral Vaccines Revenue Market Share by Application (2015-2020)
5.1.3 Global Viral Vaccines Price by Application (2015-2020)
5.2 Global Viral Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Viral Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Viral Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Viral Vaccines Price Forecast by Application (2021-2026)
6 United States Viral Vaccines Market Facts & Figures
6.1 United States Viral Vaccines Sales Market Share by Company (2015-2020)
6.2 United States Viral Vaccines Sales Market Share by Type (2015-2020)
6.3 United States Viral Vaccines Sales Market Share by Application (2015-2020)
7 Europe Viral Vaccines Market Facts & Figures
7.1 Europe Viral Vaccines Sales Market Share by Company (2015-2020)
7.2 Europe Viral Vaccines Sales Market Share by Type (2015-2020)
7.3 Europe Viral Vaccines Sales Market Share by Application (2015-2020)
8 China Viral Vaccines Market Facts & Figures
8.1 China Viral Vaccines Sales Market Share by Company (2015-2020)
8.2 China Viral Vaccines Sales Market Share by Type (2015-2020)
8.3 China Viral Vaccines Sales Market Share by Application (2015-2020)
9 Japan Viral Vaccines Market Facts & Figures
9.1 Japan Viral Vaccines Sales Market Share by Company (3015-3030)
9.2 Japan Viral Vaccines Sales Market Share by Type (2015-2020)
9.3 Japan Viral Vaccines Sales Market Share by Application (2015-2020)
10 Southeast Asia Viral Vaccines Market Facts & Figures
10.1 Southeast Asia Viral Vaccines Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Viral Vaccines Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Viral Vaccines Sales Market Share by Application (2015-2020)
11 India Viral Vaccines Market Facts & Figures
11.1 India Viral Vaccines Sales Market Share by Company (2015-2020)
11.2 India Viral Vaccines Sales Market Share by Type (2015-2020)
11.3 India Viral Vaccines Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Viral Vaccines Business
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Business Overview
12.1.3 GSK Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GSK Viral Vaccines Products Offered
12.1.5 GSK Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Viral Vaccines Products Offered
12.2.5 Merck Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Viral Vaccines Products Offered
12.3.5 Novartis Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Viral Vaccines Products Offered
12.4.5 Pfizer Recent Development
12.5 Sanofi
12.5.1 Sanofi Corporation Information
12.5.2 Sanofi Business Overview
12.5.3 Sanofi Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi Viral Vaccines Products Offered
12.5.5 Sanofi Recent Development
12.6 Bayer
12.6.1 Bayer Corporation Information
12.6.2 Bayer Business Overview
12.6.3 Bayer Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bayer Viral Vaccines Products Offered
12.6.5 Bayer Recent Development
12.7 Zoetis
12.7.1 Zoetis Corporation Information
12.7.2 Zoetis Business Overview
12.7.3 Zoetis Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Zoetis Viral Vaccines Products Offered
12.7.5 Zoetis Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Corporation Information
12.8.2 AstraZeneca Business Overview
12.8.3 AstraZeneca Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.8.4 AstraZeneca Viral Vaccines Products Offered
12.8.5 AstraZeneca Recent Development
12.9 Johnson
12.9.1 Johnson Corporation Information
12.9.2 Johnson Business Overview
12.9.3 Johnson Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Johnson Viral Vaccines Products Offered
12.9.5 Johnson Recent Development
12.10 CSL
12.10.1 CSL Corporation Information
12.10.2 CSL Business Overview
12.10.3 CSL Viral Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.10.4 CSL Viral Vaccines Products Offered
12.10.5 CSL Recent Development
13 Viral Vaccines Manufacturing Cost Analysis
13.1 Viral Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Viral Vaccines
13.4 Viral Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Viral Vaccines Distributors List
14.3 Viral Vaccines Customers
15 Market Dynamics
15.1 Viral Vaccines Market Trends
15.2 Viral Vaccines Opportunities and Drivers
15.3 Viral Vaccines Market Challenges
15.4 Viral Vaccines Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Viral Vaccines Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Viral Vaccines Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Viral Vaccines Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Viral Vaccines Sales (K MT) by Region (2015-2020)
Table 5. Global Viral Vaccines Sales Market Share by Region (2015-2020)
Table 6. Global Viral Vaccines Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Viral Vaccines Revenue Share by Region (2015-2020)
Table 8. Global Viral Vaccines Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Viral Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Viral Vaccines Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Viral Vaccines Revenue Share Forecast by Region (2021-2026)
Table 12. Global Viral Vaccines (K MT) of Key Companies (2015-2020)
Table 13. Global Viral Vaccines Sales Share by Company (2015-2020)
Table 14. Global Viral Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Viral Vaccines Revenue Share by Company (2015-2020)
Table 16. Global Viral Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vaccines as of 2019)
Table 17. Global Viral Vaccines Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Viral Vaccines Manufacturing Sites and Area Served
Table 19. Manufacturers Viral Vaccines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Viral Vaccines Players
Table 22. Global Viral Vaccines Sales (K MT) by Type (2015-2020)
Table 23. Global Viral Vaccines Sales Share by Type (2015-2020)
Table 24. Global Viral Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Viral Vaccines Price (K MT) by Type (2015-2020)
Table 26. Global Viral Vaccines Sales Share by Type (2021-2026)
Table 27. Global Viral Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Viral Vaccines Revenue Share by Type (2021-2026)
Table 29. Global Viral Vaccines Price (K MT) by Type (2021-2026)
Table 30. Global Viral Vaccines Sales (K MT) by Application (2015-2020)
Table 31. Global Viral Vaccines Sales Share by Application (2015-2020)
Table 32. Global Viral Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Viral Vaccines Price (K MT) by Application (2015-2020)
Table 34. Global Viral Vaccines Sales (K MT) by Application (2021-2026)
Table 35. Global Viral Vaccines Sales Share by Application (2021-2026)
Table 36. Global Viral Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Viral Vaccines Revenue Share by Application (2021-2026)
Table 38. Global Viral Vaccines Price (K MT) by Application (2021-2026)
Table 39. United States Viral Vaccines Sales (K MT) by Company (2015-2020)
Table 40. United States Viral Vaccines Sales Market Share by Company (2015-2020)
Table 41. United States Viral Vaccines Sales (K MT) by Type (2015-2020)
Table 42. United States Viral Vaccines Sales Market Share by Type (2015-2020)
Table 43. United States Viral Vaccines Sales (K MT) by Application (2015-2020)
Table 44. United States Viral Vaccines Sales Market Share by Application (2015-2020)
Table 45. Europe Viral Vaccines Sales (K MT) by Company (2015-2020)
Table 46. Europe Viral Vaccines Sales Market Share by Company (2015-2020)
Table 47. Europe Viral Vaccines Sales (K MT) by Type (2015-2020)
Table 48. Europe Viral Vaccines Sales Market Share by Type (2015-2020)
Table 49. Europe Viral Vaccines Sales (K MT) by Application (2015-2020)
Table 50. Europe Viral Vaccines Sales Market Share by Type (2015-2020)
Table 51. China Viral Vaccines Sales (K MT) by Company (2015-2020)
Table 52. China Viral Vaccines Sales Market Share by Company (2015-2020)
Table 53. China Viral Vaccines Sales (K MT) by Type (2015-2020)
Table 54. China Viral Vaccines Sales Market Share by Type (2015-2020)
Table 55. China Viral Vaccines Sales (K MT) by Application (2015-2020)
Table 56. China Viral Vaccines Sales Market Share by Application (2015-2020)
Table 57. Japan Viral Vaccines Sales (K MT) by Company (2015-2020)
Table 58. Japan Viral Vaccines Sales Market Share by Company (2015-2020)
Table 59. Japan Viral Vaccines Sales (K MT) by Type (2015-2020)
Table 60. Japan Viral Vaccines Sales Market Share by Type (2015-2020)
Table 61. Japan Viral Vaccines Sales (K MT) by Application (2015-2020)
Table 62. Japan Viral Vaccines Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Viral Vaccines Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Viral Vaccines Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Viral Vaccines Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Viral Vaccines Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Viral Vaccines Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Viral Vaccines Sales Market Share by Application (2015-2020)
Table 69. India Viral Vaccines Sales (K MT) by Company (2015-2020)
Table 70. India Viral Vaccines Sales Market Share by Company (2015-2020)
Table 71. India Viral Vaccines Sales (K MT) by Type (2015-2020)
Table 72. India Viral Vaccines Sales Market Share by Type (2015-2020)
Table 73. India Viral Vaccines Sales (K MT) by Application (2015-2020)
Table 74. India Viral Vaccines Sales Market Share by Application (2015-2020)
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Viral Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. GSK Viral Vaccines Product
Table 79. GSK Recent Development
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Viral Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Merck Viral Vaccines Product
Table 84. Merck Recent Development
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Viral Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Novartis Viral Vaccines Product
Table 89. Novartis Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Viral Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Pfizer Viral Vaccines Product
Table 94. Pfizer Recent Development
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Viral Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Sanofi Viral Vaccines Product
Table 99. Sanofi Recent Development
Table 100. Bayer Corporation Information
Table 101. Bayer Description and Business Overview
Table 102. Bayer Viral Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Bayer Viral Vaccines Product
Table 104. Bayer Recent Development
Table 105. Zoetis Corporation Information
Table 106. Zoetis Description and Business Overview
Table 107. Zoetis Viral Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Zoetis Viral Vaccines Product
Table 109. Zoetis Recent Development
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Viral Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. AstraZeneca Description and Business Overview
Table 113. AstraZeneca Viral Vaccines Product
Table 114. AstraZeneca Recent Development
Table 115. Johnson Corporation Information
Table 116. Johnson Viral Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Johnson Description and Business Overview
Table 118. Johnson Viral Vaccines Product
Table 119. Johnson Recent Development
Table 120. CSL Corporation Information
Table 121. CSL Description and Business Overview
Table 122. CSL Viral Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. CSL Viral Vaccines Product
Table 124. CSL Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Viral Vaccines Distributors List
Table 128. Viral Vaccines Customers List
Table 129. Viral Vaccines Market Key Trends
Table 130. Viral Vaccines Key Opportunities and Drivers
Table 131. Viral Vaccines Market Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Viral Vaccines Product Picture
Figure 2. Global Viral Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Viral Vaccines Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Pharmaceutical Factory Examples
Figure 8. Research Institute Examples
Figure 9. Others Examples
Figure 10. Global Viral Vaccines Sales (K MT) Growth Rate (2015-2026)
Figure 11. Global Viral Vaccines Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Viral Vaccines Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Viral Vaccines Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Viral Vaccines Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Viral Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Viral Vaccines Sales (K MT) Growth Rate (2015-2026)
Figure 17. Europe Viral Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Viral Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Viral Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Viral Vaccines Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Viral Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Viral Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Viral Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Viral Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Viral Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Viral Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Viral Vaccines Players Market Share by Revenue in Viral Vaccines 2015 & 2019
Figure 28. Viral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Viral Vaccines Revenue Share by Type (2015-2020)
Figure 30. Global Viral Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Viral Vaccines Revenue Share by Application (2015-2020)
Figure 32. Global Viral Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Viral Vaccines Sales Market Share by Type in 2019
Figure 34. United States Viral Vaccines Sales Market Share by Type in 2019
Figure 35. Europe Viral Vaccines Sales Market Share by Company in 2019
Figure 36. Europe Viral Vaccines Sales Market Share by Type in 2019
Figure 37. Europe Viral Vaccines Sales Market Share by Application in 2019
Figure 38. China Viral Vaccines Sales Market Share by Company in 2019
Figure 39. China Viral Vaccines Sales Market Share by Type in 2019
Figure 40. China Viral Vaccines Sales Market Share by Application in 2019
Figure 41. Japan Viral Vaccines Sales Market Share by Company in 2019
Figure 42. Japan Viral Vaccines Sales Market Share by Type in 2019
Figure 43. Japan Viral Vaccines Sales Market Share by Application in 2019
Figure 44. Southeast Asia Viral Vaccines Sales Market Share by Company in 2019
Figure 45. Southeast Asia Viral Vaccines Sales Market Share by Type in 2019
Figure 46. Southeast Asia Viral Vaccines Sales Market Share by Application in 2019
Figure 47. India Viral Vaccines Sales Market Share by Company in 2019
Figure 48. India Viral Vaccines Sales Market Share by Type in 2019
Figure 49. India Viral Vaccines Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Viral Vaccines
Figure 52. Manufacturing Process Analysis of Viral Vaccines
Figure 53. Viral Vaccines Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
ワクチンの世界市場レポート2020 A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates …- トラベラーズワクチンの世界市場レポート2020 A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates …
- DNAワクチンの世界市場レポート2020 The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines. N…
- ジカウイルスワクチンの世界市場レポート2020 Market Analysis and Insights: Global Zika Virus Vaccines Market The global Zika Virus Vaccines market size is projected to reach US$ 16010 million by 2026, from US$ 13450 million in 2020, at a CAGR of 2.9% during 2021-2026. Global Zika Virus Vaccines Scope and Market Size The global Zika Virus Vacci…
- 豚用ワクチンの世界市場レポート2020 The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination. Vaccines contain antigens from vi…